黑料官网

header-logo
GettyImages-609179959-hero
Hematology and Oncology
Stolley PCCOE

Melinda Stolley, PhD

Ann E. Heil Professor of Cancer Research, Associate Director of Population Sciences and Co-Leader, Cancer Control research program, Cancer Center; Professor, Medicine (Hematology/Oncology)

Locations

  • Hematology and Oncology

Contact Information

Research Experience

  • Health Behavior

Leadership Positions

  • Associate Director of Cancer Prevention and Control

Research Interests

Dr. Stolley is a health psychologist with expertise in behavioral interventions across the cancer continuum. Her research focuses on lifestyle behavior change to improve patient-reported and cancer outcomes. She has nearly 25 years of experience developing and testing lifestyle change interventions among children, adults and cancer survivors. An important aspect of this work is her focus on partnering with underserved communities to identify and pursue relevant research questions. Dr. Stolley has a strong portfolio of NCI-funded grants to examine the effects of lifestyle interventions on behavioral, psychosocial and physiological outcomes. Her work also seeks to understand the mechanistic pathways that link behavior change to improved patient-reported and cancer outcomes. Dr. Stolley co-leads the Statewide Community and Cancer Science Network which applies a novel transdisciplinary approach to transform community-academic partnerships to address cancer disparities. Dr. Stolley is deeply committed to training and facilitating a diverse workforce. She leads the NCI T32-funded Biobehavioral Oncology Postdoctoral Training Program at 黑料官网 with Dr. Jennifer Knight. Dr. Stolley also initiated and directs a summer cancer disparities research training program for undergraduates and first year medical students and partnered with Milwaukee Public Schools to develop a high school cancer education program.

Publications

  • (Henley EC, Liphart HA, Morris KJ, Awoyinka I, Irwin MR, Costanzo ES, Winston D, D'Souza A, Stolley M, Dhakal B, Mohan M, Pasquini MC, Cole SW, Doerwald ES, Bendis PC, Rentscher KE, Rumble ME, Szabo A, Rao S, Knight JM.) Contemp Clin Trials Commun. 2025 Oct;47:101540 PMID: 40893725 PMCID: PMC12397865 09/02/2025

  • (Do Couto N, Hidde M, Grigoriadis G, Sparapani R, Durand M, Widlansky M, Jankowski C, Berendt M, Canales B, Golus S, Norwood Toro LE, Laud P, Kong A, Hoskins K, Lewandowski D, Phillips SA, Gutterman DD, Kriegel AJ, Beyer KMM, Beyer AM, Stolley M.) Cardiooncology. 2025 Aug 21;11(1):75 PMID: 40841694 PMCID: PMC12369258 SCOPUS ID: 2-s2.0-105014033548 08/22/2025

  • (Chan K, Cotler JH, Istl AC, Kamaraju S, Petroll AE, Stolley M, Cortina CS.) JAMA Oncol. 2025 Jul 01;11(7):786-789 PMID: 40402506 PMCID: PMC12100505 SCOPUS ID: 2-s2.0-105006601758 05/22/2025

  • (Riegel DC, Kwarteng JL, Pinsoneault L, Contreras S, Wasserman E, Visotcky A, Manriquez Prado A, Villarreal Espinosa O, Sheean P, Tovar M, Jensik K, Vidaver RM, Stolley MR.) J Cancer Educ. 2025 Mar 29 PMID: 40156663 03/30/2025

  • (Neuner JM, Stolley M, Kamaraju S, Tiegs J, Sparapani R, Makris V, Flynn KE.) Breast Cancer Res Treat. 2025 Feb;209(3):541-552 PMID: 39592520 SCOPUS ID: 2-s2.0-85210370572 11/27/2024

  • (Kwarteng JL, Sheean P, Pinsoneault L, Contreras S, Aboagye S, Wasserman E, Vidaver RM, O'Connell K, Tovar M, Manriquez Prado A, Stolley MR.) Transl Behav Med. 2025 Jan 16;15(1) PMID: 41165249 SCOPUS ID: 2-s2.0-105020257337 10/30/2025

  • (Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS.) Ann Surg Oncol. 2024 Sep;31(9):5560-5569 PMID: 38861206 PMCID: PMC11309885 SCOPUS ID: 2-s2.0-85195645715 06/11/2024

  • (Kamaraju S, McKoy J, Williams GR, Gilmore N, Minami C, Bylow K, Rajalingam H, Cortina CS, Beckert A, Stolley M, Bullock D, Kurzrock R, Jatoi A.) Curr Oncol Rep. 2024 Aug;26(8):855-864 PMID: 38801612 PMCID: PMC11300154 SCOPUS ID: 2-s2.0-85194589535 05/27/2024

  • (SenthilKumar G, Schottstaedt AM, Peterson LL, Pedersen LN, Chitambar CR, Vistocky A, Banerjee A, Longo JM, Kelly T, Currey A, Stolley MR, Bergom C.) Cancer Res Commun. 2024 May 07;4(5):1211-1226 PMID: 38530195 PMCID: PMC11075661 SCOPUS ID: 2-s2.0-85193115138 03/26/2024

  • (Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE.) Support Care Cancer. 2024 Apr 02;32(4):265 PMID: 38565669 PMCID: PMC11698022 SCOPUS ID: 2-s2.0-85189209769 04/03/2024

  • (Kwarteng JL, White K, Nevels D, Brown S, Stolley MR.) J Relig Health. 2024 Apr;63(2):1523-1537 PMID: 38453721 PMCID: PMC11672192 SCOPUS ID: 2-s2.0-85186850594 03/08/2024

  • (Awoyinka I, Tovar M, Young S, Beyer K, Kwarteng J, Knight J, Stolley M.) Support Care Cancer. 2024 Feb 21;32(3):178 PMID: 38381216 PMCID: PMC12108550 SCOPUS ID: 2-s2.0-85185668818 02/21/2024

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.